Assessing melanoma risk factors: How closely do patients and doctors agree?

Public Health

Volumn 122, Issue 12, 2008, Pages 1433-1439

  Richtig, E ^a   Santigli, E ^a   Fink Puches, R ^a   Weger, W ^a   Hofmann Wellenhof, R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Melanoma; Melanoma risk; Naevi; Self assessment; Skin phototype

Indexed keywords

DISEASE CONTROL; RISK FACTOR; SELF ASSESSMENT; SKIN DISORDER;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRIA; CANCER RISK; CAUCASIAN; CHILD; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH EDUCATION; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MELANOMA; NEVUS; PATIENT REFERRAL; RISK ASSESSMENT; RISK FACTOR; SELF EXAMINATION; SEX DIFFERENCE; SKIN EXAMINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; CHILD; CHILD, PRESCHOOL; DERMATOLOGY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INFANT; MALE; MASS SCREENING; MELANOMA; MIDDLE AGED; PUBLIC HEALTH; PUBLIC HEALTH PRACTICE; QUESTIONNAIRES; RISK FACTORS; SELF-EXAMINATION; YOUNG ADULT;

AUSTRIA; CENTRAL EUROPE; EURASIA; EUROPE; STYRIA;

EID: 55949104330     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.puhe.2008.04.012     Document Type: Article

References (30)

1. Blum A., Garbe C., and Rassner G. Prävention des malignen Melanoms. Hautarzt 49 (1998) 826-834
2. Marks R. Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now. Australas J Dermatol 40 (1999) 1-5
3. Pehamberger H., Binder M., Knollmayer S., and Wolff K. Immediate effects of a public education campaign on prognostic features of melanoma. J Am Acad Dermatol 29 (1993) 106-109
4. Pehamberger H. 10 Jahre Sonne ohne Reue. In: Wayand W., and Pehamberger H. (Eds). Onkologisch (1998), Österreichische Krebshilfe-Krebsgesellschaft, Vienna 31
5. Paul C., Tzelepis F., Walsh R.A., Girgis A., King L., and McKenzie J. Has the investment in public cancer education delivered observable changes in knowledge over the past 10 years?. Cancer 97 (2003) 2931-2939
6. Rivers J.K., and Burton R.C. Prevention strategies, early detection and results of education programs. In: Thompson J.F., Morton D.L., and Kroon B.B.R. (Eds). Textbook of melanoma (2004), Dunitz, London 81-89
7. Wolfe J.T. The role of screening in the management of skin cancer. Curr Opin Oncol 11 (1999) 123-128
8. Aitken J., and Elwood M. Population screening for melanoma: current evidence and a community based randomized trial. In: Thompson J.F., Morton D.L., and Kroon B.B.R. (Eds). Textbook of melanoma (2004), Dunitz, London 100-114
9. Garbe C., McLeod G.R., and Buettner P. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89 (2000) 1269-1278
10. Diepgen T.L., and Mahler V. The epidemiology of skin cancer. Br J Dermatol 146 Suppl (2002) 1S-6S
11. Harbauer A., Binder M., Pehamberger H., Wolff K., and Kittler H. Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk. Melanoma Res 13 (2003) 537-542
12. Carli P., de Giorgi V., Nardini P., Mannone F., Palli D., and Gianotti B. Melanoma detection rate and concordance between self-skin examination and clinical evaluation in patients attending a pigmented lesion clinic in Italy. Br J Dermatol 146 (2002) 261-266
13. Eiser J.R., Pendry L., Greaves C.J., Melia J., Harland C., and Moss S. Is targeted early detection for melanoma feasible? Self assessments of risk and attitudes to screening. J Med Screen 7 (2000) 199-202
14. Koh H.K., Norton L.A., Geller A.C., Sun T., Rigel D.S., Miller D.R., et al. Evaluation of the American Academy of Dermatology's National skin cancer early detection and screening program. J Am Acad Dermatol 34 (1996) 971-978
15. Geller A.C., Zhang Z., Sober A.J., Halpern A.C., Weinstock M.A., Daniels S., et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol 48 (2003) 34-41
16. Carli P., Nardini P., Crocetti E., De Giorni V., and Gianotti B. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study. Melanoma Res 14 (2004) 403-407
17. Hofmann-Wellenhof R., Soyer H.P., Richtig E., Wolf I.H., Smolle J., Scherer C., et al. Should dermatologists go public? A skin cancer screening campaign at recreation centers. Arch Dermatol 136 (2000) 938-940
18. Elwood J.M. Screening for melanoma and options for its evaluation. J Med Screen 1 (1994) 22-38
19. Holme S.A., Varma S., Chowdhury M.M., and Roberts D.L. Audit of a melanoma screening day in the U.K.: clinical results, participant satisfaction and perceived value. Br J Dermatol 145 (2001) 784-788
20. Carli P., De Giorgi V., Giannotti B., Seidenari S., Pellacani G., Peris K., et al. Skin cancer day in Italy: method of referral to open access clinics and tumor prevalence in the examined population. Eur J Dermatol 13 (2003) 76-79
21. De Rooij M.J., Rampen F.H., Schouten L.J., and Neumann H.A. Total skin examination during screening for malignant melanoma does not increase the detection rate. Br J Dermatol 135 (1996) 42-45
22. Geller A.C., Sober A.J., Zhang Z., Brooks D.R., Miller D.R., Halpern A., et al. Strategies for improving melanoma education and screening for men age ≥ 50 years. Cancer 95 (2002) 1554-1561
23. De Rooij M.J., Rampen F.H., Schouten L.J., and Neumann H.A. Factors influencing participation among melanoma screening attenders. Acta Derm Venerol 77 (1997) 467-470
24. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124 (1988) 869-871
25. Garbe C., Buettner P., Weiss J., Soyer H.P., Stocker U., Krüger S., et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 102 (1994) 700-705
26. Vassar Stats: website for statistical computation. Available from. http://faculty.vassar.edu/lowry/kappaexp.html
27. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159
28. Garbe C. Sonne und malignes Melanom. Hautarzt 43 (1992) 251-257
29. Nijsten T., Leys C., Verbruggen K., Verlinden V., Drieghe J., Stas M., et al. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination. J Eur Acad Dermatol Venereol 19 (2005) 332-339
30. Armstrong B. Epidemiology of cutaneous melanoma and current trends. In: Thompson J.F., Morton D.L., and Kroon B.B.R. (Eds). Textbook of melanoma (2004), Dunitz, London 65-80